Therapeutic injectable analgesic pharmaceutical composition containing nimesulide 4-nitro, 2-phenoxyphenyl methane sulphonamide for intramuscular administration
CA 2188703 C · Owner: Panacea Biotec Limited · Inventors: Jain, Rajesh; Singh, Amarjit
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A novel therapeutic injectable analgesic pharmaceutical composition containing Nimesulide for intramuscular administration is disclosed. The composition comprises nimesulide and a parenteral absorption enhancing vehicle base. The parenteral absorption enhancing vehicle base comprises dimethylacetamide benzyl benzoate, benzyl alcohol, ethyl oleate. Also disclosed is a process for the manufacture of a novel therapeutic injectable analgesic pharmaceutical composition containing Nimesulide. The composition shows marked analgesic composition and is very effective and useful for the treatment of acute painful conditions like post-operative trauma pain associated with cancer, sport, injuries and …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 24, 1996 and granted April 24, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 24, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 24, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.